Home > Cashflow Statement > NATCO PHARMA

NATCO PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Operating Activities ₹1,212 Cr₹849 Cr₹47 Cr₹299 Cr₹417 Cr

What is the latest Cash Flow from Operating Activities ratio of NATCO PHARMA ?

The latest Cash Flow from Operating Activities ratio of NATCO PHARMA is ₹1,212 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Operating Activities
Mar2024₹1,212 Cr
Mar2023₹849 Cr
Mar2022₹47 Cr
Mar2021₹299 Cr
Mar2020₹417 Cr

How is Cash Flow from Operating Activities of NATCO PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2024 ₹1,212 Cr
42.69
Mar2023 ₹849 Cr
1,726.02
Mar2022 ₹47 Cr
-84.44
Mar2021 ₹299 Cr
-28.40
Mar2020 ₹417 Cr -

Compare Cash Flow from Operating Activities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹22,124.2 Cr 6.4% -6.9% 35.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹423,974.0 Cr 1.3% -4.7% 22.8% Stock Analytics
DIVIS LABORATORIES ₹161,729.0 Cr 6.3% 3.3% 59.2% Stock Analytics
CIPLA ₹116,999.0 Cr -0.7% -3.3% 2.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,771.0 Cr 2.1% -9.7% -0.3% Stock Analytics
ZYDUS LIFESCIENCES ₹97,951.9 Cr 2.1% -2.8% 26.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

6.4%

-6.9%

35.3%

SENSEX

2.7%

0.8%

9.7%


You may also like the below Video Courses